2024-03-28T10:05:43Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00006435
2022-12-15T03:39:42Z
453:456
471:537:568:619
K-ras Mutations in Gallbladder Carcinomas in Patients with Anomalous Arrangement of the Pancreaticobiliary Duct
K-ras Mutations in Gallbladder Carcinomas in Patients with Anomalous Arrangement of the Pancreaticobiliary Duct
Itoi, Takao
Watanabe, Hidenobu
Yoshikawa, Tatsuya
Ajioka, Yoichi
Nishikura, Ken
Saito, Toshihiko
K-ras
cell-proliferative activity
APBD
Mutation of the K-ras codon 12 was examined in 17 gallbladder carcinomas and 14 nonneoplastic gallbladder mucosa in patients with anomalous arrangement of the pancreaticobiliary duct (APBD), using nested polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. In addition, we investigated the relationship between the K-ras mutation and cellular proliferation using Ki-67 (MIB1) monoclonal antibody. Mutation of K-ras codon 12 was found in 7 of 17 (41.2%) gallbladder carcinomas but not in nonneoplastic gallbladder mucosa. There was neither a correlation between the presence of the K-ras mutation and the size or depth of invasion of the carcinoma, nor any statistically significant difference in cellular proliferation of the same grade of cytologic atypia between tumors with and without K-ras mutation (Ki-67 labeling index, high grade; 35.2 ±13.3% and 31.6±13.9%, low grade; 14.2±4.9% and 21.2± 12.8%, respectively). This indicates that mutation of K- ras codon 12 may be involved in the development of gallbladder carcinomas preferentially in patients with APBD, but not in the progression of the Ki-67 labeling index, tumor size, or tumor invasion.
Niigata University School of Medicine
1996-06
eng
departmental bulletin paper
http://hdl.handle.net/10191/33162
https://niigata-u.repo.nii.ac.jp/records/6435
AA00508361
05677734
Acta medica et biologica
Acta medica et biologica
44
2
71
77
https://niigata-u.repo.nii.ac.jp/record/6435/files/44(2)_71-77.pdf
application/pdf
1.3 MB
2019-08-06